Identifying ferroptosis-related genes in lung adenocarcinoma using random walk with restart in the PPI network.

Journal: Scientific reports
Published Date:

Abstract

Lung adenocarcinoma (LUAD), the most common non-small cell lung cancer subtype, often presents with subtle early symptoms leading to delayed diagnosis. Ferroptosis, a cell death process associated with iron metabolism dysregulation, has been linked to cancer onset, progression, and treatment resistance. Thus, identifying ferroptosis-related genes may offer novel insights for LUAD therapy. In this study, we employed the random walk with restart (RWR) algorithm on the LUAD protein-protein interaction (PPI) network to predict ferroptosis-related target genes. Gene set enrichment analysis (GSEA) explored the relationship between XBP1 and ferroptosis, while tumor microenvironment analysis evaluated the correlation between XBP1 expression and immune cell infiltration. External cohorts validation was performed using the GSE118370, GSE68465, and TCGA-LUAD datasets. Our analysis identified XBP1 as a potential ferroptosis-related gene in LUAD. GSEA confirmed a strong association between XBP1 and the ferroptosis process, along with its involvement in the tumor microenvironment, and external cohorts demonstrated its high expression and significant correlation with immune cell infiltration in LUAD tissues. These findings suggest that XBP1 plays a key role in LUAD development and progression, providing new perspectives for precision therapies targeting the ferroptosis pathway.

Authors

  • Can Liu
    School of Medical Informatics Engineering, Anhui University of Chinese Medicine, Hefei, Anhui 230012, China.
  • Peng He
    Key Laboratory of Sensor Analysis of Tumor Marker, Ministry of Education, College of Chemistry and Molecular Engineering, Qingdao University of Science and Technology, Qingdao 266042, PR China.
  • Ru Qiao
    College of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China; Hunan Provincial Key Laboratory of Drugability and Preparation Modification of TCM, Changsha, 410208, China. Electronic address: 2604806572@qq.com.
  • Xiaoyan Yang
  • Changsong Ding
    School of Informatics, Hunan University of Chinese Medicine, Changsha, Hunan, 410208, China. Electronic address: dingcs1975@hnucm.edu.cn.
  • Fuyuan He
    College of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China; Hunan Provincial Key Laboratory of Drugability and Preparation Modification of TCM, Changsha, 410208, China. Electronic address: pharmsharking@163.com.